The Novor team will be flying into Boston again next week attending the Discovery on Target conference.

On Wednesday morning, Mingjie, our co-founder and CEO, will give a talk on the topic of Sequencing Antibody Proteins with Mass Spectrometry. Mingjie will share the best practices we developed during our journey sequencing hundreds of antibody proteins for our customers. Here are the key points:

  • Examine individual amino acids
  • Pay attention to CDR3
  • Distinguish Isoleucine and Leucine

We invite you for a discussion at our booth # 513. Or you can always setup a free consultation on how we may help in your research project via this form.

Sign up for the newsletter.

Sign up for the next webinar.

Whitepaper: Prevalence of Secondary Light Chains

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 3000 antibodies and we are eager to help you.